Videos

There are a number of pulmonary embolism warning signs patients with cancer and their caregivers should watch for.

Heather Quintana Suchan says early biomarker testing at diagnosis helped match her to Rybrevant and urges patients to personalize care and stay active during treatment.

A liver cancer survivor shares transplant insights, dispels living donor myths and urges patients to advocate for informed, hopeful care.

A three-time cervical cancer survivor urges patients with cancer to be thorough, seek multiple opinions and trust their gut to find providers who listen, validate concerns and truly support them.

Dr. Sue Hwang, a radiation oncologist and breast cancer survivor, sheds light on the reality of cancer survivorship.

CURE spoke with a provider and a survivor about the potential power of minimal residual disease testing.

In an interview, liver cancer survivor Charles Walker shared how family support and a living donor transplant changed his treatment journey and outlook.

The FDA approved Darzalex Faspro with Velcade, Revlimid and dexamethasone for newly diagnosed multiple myeloma ineligible for autologous stem cell transplant.

Former NFL player and advocate Chris Draft urges patients with cancer to recognize small actions, learn terms and stay engaged to rebuild confidence after diagnosis.

Colleen Mabasa shared her experience navigating CAR-T cell therapy beyond the clinical aspects of treatment.

In a recent CURE conversation, Charles Walker shared how months of unexplained fatigue and back pain ultimately led to a life-altering diagnosis.

CURE spoke with Dr. Kathie-Ann Joseph about the importance of personalized, multidisciplinary treatments when caring for patients with breast cancer.

Dr. Sue Hwang explains how she went from a care provider who helped others through their cancer journeys to a patient facing a cancer diagnosis of her own.

USC doctors say careful staging and tumor testing help younger patients choose surgery and targeted treatments based on their cancer.

Dr. Elias Obeid says ongoing monitoring after treatment helps detect recurrence early and identify late effects, supporting survivorship for patients.

Dr. Suneel Kamath emphasized the growing importance of understanding biomarkers in patients with gastrointestinal cancers.

Relacorilant plus Abraxane showed benefit without biomarker testing, potentially expanding treatment access for patients with platinum-resistant ovarian cancer.

Dietitians share a fiber- and protein-rich pastina bean soup to help patients with colorectal cancer stay nourished and manage gastrointestinal symptoms during treatment.

World Cancer Day highlights the global impact of cancer, raising awareness, fostering unity and reminding us to support survivors and patients together.

In closing, the panel of experienced multiple myeloma care partners offers a powerful, unified message of hope and actionable advice.

A common care partner challenge is managing guilt when engaging in activities for personal wellness, especially if the multiple myeloma patient cannot participate.

Former U.S. goalkeeper opens up about a large B-cell lymphoma diagnosis and finally reaching remission after chimeric antigen receptor T cell therapy, urging patients to advocate and seek options.

Dr. Joshua K. Sabari explains how surgery, radiation and therapy may reduce lung capacity and shares steps survivors can take to protect their breathing health.

CURE recently spoke with CEPHEUS study investigator Dr. Saad Z. Usmani, chief of the myeloma service at Memorial Sloan Kettering Cancer Center.

A gynecologic oncologist discusses staging, treatment choices, sexual health, mental health and HPV vaccination during cervical cancer awareness month.

Dr. Suneel Kamath addresses patient concerns on the topic of clinical trial participation in the gastrointestinal cancer treatment space.

CURE sat down with Dr. Kathie-Ann Joseph to discuss surgical advancements for individuals with breast cancer.

Minimal residual disease testing can offer psychological comfort to patients and survivors as well as insight into potential treatment strategies for care providers.

Risk assessment helps patients understand why cancer occurred, the role of genetics, treatment options and prevention strategies for themselves and family.

Dr. Suneel Kamath discusses the importance of biomarker-driven approaches in cancer care following the 2026 ASCO GI Symposium.